A SIMPLE blood test will soon allow doctors to identify patients whose
high blood pressure is caused by an inherited sensitivity to salt.
Myriad Genetics, a biotechnology company based in Salt Lake City, Utah, has
announced that it will launch a blood test later this year for a defective gene
linked to salt-sensitive hypertension.
“It identifies those individuals who should be on low-salt diets,” says Peter
Meldrum, the company’s president.
